Details for New Drug Application (NDA): 062240
✉ Email this page to a colleague
NDA 062240 describes CLOXACILLIN SODIUM, which is a drug marketed by Apothecon and Teva and is included in four NDAs. Additional details are available on the CLOXACILLIN SODIUM profile page.
The generic ingredient in CLOXACILLIN SODIUM is cloxacillin sodium. There are twenty-three drug master file entries for this compound. Additional details are available on the cloxacillin sodium profile page.
The generic ingredient in CLOXACILLIN SODIUM is cloxacillin sodium. There are twenty-three drug master file entries for this compound. Additional details are available on the cloxacillin sodium profile page.
Summary for 062240
| Tradename: | CLOXACILLIN SODIUM |
| Applicant: | Teva |
| Ingredient: | cloxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062240
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
